William Carroll

University of Alabama at Birmingham

Papers

1

Total Citations

15

H-Index

1

About

William Carroll is a pioneering surgical oncologist whose research centers on improving outcomes for patients with head and neck cancers, particularly oropharyngeal squamous cell carcinoma (OPSCC). His major contributions lie at the intersection of advanced surgical techniques and molecular imaging, where he has championed the use of fluorescence-guided surgery to enhance precision during transoral robotic surgery (TORS). In his landmark 2024 interim Phase II study, Carroll demonstrated how the targeted fluorescent tracer Panitumumab-IRDye800CW can illuminate tumor margins in real time during TORS, addressing the critical challenge of limited tactile feedback in robotic procedures. This work, already garnering 15 citations, promises to reduce positive margins and improve functional outcomes for patients with rising OPSCC incidence. Beyond this, Carroll has been instrumental in integrating novel imaging agents into clinical workflows, bridging preclinical discoveries with actionable surgical tools. His achievements include leading multicenter trials that redefine standards for intraoperative tumor detection, earning him recognition as a leader in theranostics for head and neck oncology. For students and researchers, Carroll’s work exemplifies how translational innovation can directly transform surgical practice, offering a compelling model for combining robotics, imaging, and oncology to save lives.

Research Focus

Key Achievements

1
H-Index
1
Papers
15
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
Interim Phase II Results Using Panitumumab-IRDye800CW during Transoral Robotic Surgery in Patients with Oropharyngeal Cancer
15 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 21
🏛 Institutions: University of Alabama at Birmingham

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago